Tempus AI, Inc. (NASDAQ:TEM) Given Average Rating of “Moderate Buy” by Analysts

Shares of Tempus AI, Inc. (NASDAQ:TEM) have earned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $54.22.

TEM has been the topic of several research analyst reports. Loop Capital increased their price target on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a report on Tuesday, October 15th. JPMorgan Chase & Co. upped their price objective on Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Piper Sandler restated a “neutral” rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and upped their price objective for the stock from $45.00 to $65.00 in a research note on Monday, November 11th. Finally, Bank of America lowered Tempus AI from a “buy” rating to a “neutral” rating and upped their price objective for the stock from $45.00 to $60.00 in a research note on Wednesday, October 2nd.

Tempus AI Price Performance

NASDAQ TEM opened at $52.40 on Monday. The company’s fifty day moving average price is $51.25. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI has a 1-year low of $22.89 and a 1-year high of $79.49.

Institutional Investors Weigh In On Tempus AI

Institutional investors have recently bought and sold shares of the business. Sumitomo Mitsui Trust Group Inc. increased its stake in Tempus AI by 1,591.2% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock worth $68,922,000 after buying an additional 1,145,698 shares in the last quarter. Dakota Wealth Management purchased a new position in shares of Tempus AI during the third quarter valued at about $1,185,000. Sigma Planning Corp purchased a new position in shares of Tempus AI during the third quarter valued at about $1,323,000. Davidson Kempner Capital Management LP purchased a new position in shares of Tempus AI during the second quarter valued at about $2,271,000. Finally, NEA Management Company LLC purchased a new position in shares of Tempus AI during the second quarter valued at about $160,048,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.